| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.86B | +20.6% |
| Cost of Revenue | $4.46B | +9.5% |
| R&D Expense | $303.5M | +7.6% |
| SG&A Expense | $1.31B | +11.4% |
| Operating Income | $872.2M | +290.4% |
| Interest Expense | $180.1M | +22.3% |
| Pre-tax Income | $533.7M | +219.6% |
| Income Tax | $73.5M | -18.7% |
| Net Income | $460.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $780.4M | +199.5% |
| Accounts Receivable | $2.19B | +15.7% |
| Inventory | $884.3M | +7.6% |
| Current Assets | $4.00B | +26.7% |
| Total Assets | $8.00B | +12.7% |
| Current Liabilities | $2.31B | +21.5% |
| Long-term Debt | $2.94B | -7.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $900.5M | +689.3% |
| Capital Expenditures | $127.9M | +27.9% |
| Investing Cash Flow | -$139.1M | -24.1% |
| Financing Cash Flow | -$247.5M | -347.0% |
| Free Cash Flow | $772.6M | +405.6% |
| +500.8% |
| EPS (Basic) | $1.21 | +505.0% |
| EPS (Diluted) | $1.19 | +3075.0% |
| Total Liabilities |
| $5.98B |
| +5.8% |
| Stockholders' Equity | $2.01B | +39.7% |